Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with atrial fibrillation (AF), they are often underused in this particularly high-risk population. The aim of the present study was to assess the appropriateness of OAC prescription and its associated factors in hospitalized patients aged 65 years or older. Methods: Data were obtained from the retrospective phase of Simulation-based Technologies to Improve the Appropriate Use of Oral Anticoagulants in Hospitalized Elderly Patients With Atrial Fibrillation (SIM-AF) study, held in 32 Italian internal medicine and geriatric wards. The appropriateness of OAC prescription was assessed, grouping patients in those who were and were not prescribed OACs...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
none98noThe SIM‐AF study was funded by a competitive grant from Bristol Myers Squibb/Pfizer Alliance...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Abstract AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older peopl...
AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with ...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with ...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
none98noThe SIM‐AF study was funded by a competitive grant from Bristol Myers Squibb/Pfizer Alliance...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Abstract AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older peopl...
AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with ...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
AIMS: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with ...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
Aims: Although oral anticoagulants (OACs) are effective in preventing stroke in older people with at...
none98noThe SIM‐AF study was funded by a competitive grant from Bristol Myers Squibb/Pfizer Alliance...